JANE STREET GROUP, LLC

Position in LPCN — Lipocine Inc.

CIK 1595888 NEW YORK, NY

Position in LPCN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$243,780

+$83,765 QoQ

Shares Held

95,227

+375.5% QoQ

Ownership

1.16%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 36 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. LPCN ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	2,934,193	$218,538,693
2	MDGL	Madrigal Pharmaceuticals, Inc.	191,541	$102,847,939
3	AXSM	Axsome Therapeutics, Inc.	403,995	$98,885,855
4	TGTX	Tg Therapeutics, Inc.	1,752,646	$96,290,370
5	EXEL	Exelixis, Inc.	1,402,438	$76,306,651
6	QURE	uniQure N.V.	1,610,483	$74,178,846
7	HALO	Halozyme Therapeutics, Inc.	694,684	$54,372,915
8	TVTX	Travere Therapeutics, Inc.	938,699	$53,327,489

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$243,780	95,227	+375.5%	Shares	Defined	2026-08-14
2026-03-31	$160,015	20,027	+89.4%	Shares	Defined	2026-05-12
2025-12-31	$84,909	10,574	-74.1%	Shares	Defined	2026-02-12
2023-03-31	$12,996	40,868	+147.6%	Shares	Defined	2023-05-16
2022-12-31	$6,569	16,506	-47.7%	Shares	Defined	2023-02-15
2022-09-30	$14,189	31,532	+17.3%	Shares	Defined	2022-11-15
2022-06-30	$21,527	26,876	-12.6%	Shares	Defined	2022-08-16
2022-03-31	$42,139	30,759	+35.9%	Shares	Defined	2022-05-17
2021-12-31	$22,433	22,638	-39.6%	Shares	Defined	2022-02-15
2021-09-30	$40,855	37,482	+29.0%	Shares	Defined	2021-11-16
2021-03-31	$43,880	29,060	—	Shares	Defined	2021-05-18
No filing history on record for this holder in this stock.